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Public Health, University of Cambridge, Cambridge, UKA B S T R A C TBackground: A conceptual modeling framework is a methodology
that assists modelers through the process of developing a model
structure. Public health interventions tend to operate in dynamically
complex systems. Modeling public health interventions requires
broader considerations than clinical ones. Inappropriately simple
models may lead to poor validity and credibility, resulting in sub-
optimal allocation of resources. Objective: This article presents the
ﬁrst conceptual modeling framework for public health economic
evaluation. Methods: The framework presented here was informed
by literature reviews of the key challenges in public health economic
modeling and existing conceptual modeling frameworks; qualitative
research to understand the experiences of modelers when developing
public health economic models; and piloting a draft version of the
framework. Results: The conceptual modeling framework comprises
four key principles of good practice and a proposed methodology. The
key principles are that 1) a systems approach to modeling should be
taken; 2) a documented understanding of the problem is imperative
before and alongside developing and justifying the model structure;ee front matter Copyright & 2016, International S
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eld, South Yorkshire S1 4DA, UK.3) strong communication with stakeholders and members of the team
throughout model development is essential; and 4) a systematic
consideration of the determinants of health is central to identifying
the key impacts of public health interventions. The methodology
consists of four phases: phase A, aligning the framework with the
decision-making process; phase B, identifying relevant stakeholders;
phase C, understanding the problem; and phase D, developing and
justifying the model structure. Key areas for further research involve
evaluation of the framework in diverse case studies and the develop-
ment of methods for modeling individual and social behavior.
Conclusions: This approach could improve the quality of Public Health
economic models, supporting efﬁcient allocation of scarce resources.
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Conceptual modeling is the abstraction of elements of reality at an
appropriate level of simpliﬁcation for the problem [1]. It is the ﬁrst
part of a modeling project, which guides and affects all other stages.
If done poorly, the subsequent analysis, no matter how mathemati-
cally sophisticated, is unlikely to be useful for decision makers [2].
The absence of formal conceptual modeling may lead to a plethora
of errors including answering the wrong (or less useful) question;
poor validity and credibility; no basis for model veriﬁcation, struc-
tural uncertainty analysis, or speciﬁcation of key areas for further
research; poor transparency for stakeholders and model reuse;
ignorance of system variation; and inefﬁcient model development.In 2011 Chilcott et al. [3] highlighted the lack of formal methods
for health economic model development. Given the scientiﬁc rigor
of technical methods such as probabilistic sensitivity analysis
(PSA) for representing parameter uncertainty and the importance
placed on these approaches for health care decision making [4],
methods for the development of the model structure are relatively
underdeveloped. If the model structure is inadequate, the PSA will
provide misleading results, leading to inappropriate policy deci-
sions. The lack of formal conceptual modeling approaches is
particularly problematic for economic models of public health
interventions. Public health economic models are models of any
intervention preventing disease, prolonging life, or promoting
health. A key objective of public health is sometimes to reduceociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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V A L U E I N H E A L T H 1 9 ( 2 0 1 6 ) 5 8 8 – 6 0 1 589inequities rather than maximize the health of the society. In
addition, public health interventions tend to operate in dynam-
ically complex social systems that include the social determinants
of health [5]. The modeling described in this article seeks to
capture the complexities involved. Key challenges associated with
developing the structure of public health economic models are
described in detail by the authors in an existing article [6].
This article aims to provide a conceptual modeling framework for
developing models of public health interventions, that is, a method-
ology that helps to guide modelers through the development of a
model structure, from developing and describing an understanding of
the decision problem to the abstraction and nonsoftware-speciﬁc
description of the quantitative model, using a transparent approach
that enables each stage to be shared and questioned. It is intended to
be used by any modeler undertaking public health economic evalua-
tions. It also provides a standardized approach that will help stake-
holders to input into and use the model developed.
During the development of this framework an important
obstacle had to be confronted. Given the lack of guidance on
conceptual modeling in health economic evaluation more gen-
erally, we did not have a platform on which to build the addi-
tional considerations and differences for public health. Thus, the
aim to present a conceptual modeling framework for developing
the structure of public health models necessarily involved devel-
oping guidance that was general and also outlining speciﬁc public
health considerations that may otherwise be overlooked. While
our work has been underway, the lack of conceptual modeling
guidance has been recognized as an issue within the wider health
economics community, with the International Society for Phar-
macoeconomics and Outcomes Research and the Society for
Medical Decision Making (ISPOR-SMDM) Joint Modeling Good
Research Practices Task Force developing guidance to inform
conceptual modeling for health economics [7]. The ISPOR guid-
ance describes what modelers should do, but it does not describe
how they might do it. Thus all parts of the framework are new in
that they describe methods to help health economic modelers
develop model structures, whilst speciﬁc public health consid-
erations are mainly outlined in those areas of the framework
dealing with developing an understanding of the decision
problem. When methods or processes in the framework are
established we provide references to key literature. Methods or
processes are outlined in detail if they have not been described
previously for health economic modeling.
The parallel development of our framework and the ISPOR
guidance highlights the importance and timely nature of this work.
We intend that this guidance will complement and add to the ISPOR
conceptual modeling guidance by helping modelers think about
their approach to model development. It is not intended to provide a
checklist for developing “good” model structures. Given its purpose,
it is necessary to provide a good deal of detail.Methods for Developing the Conceptual Modeling
Framework
The conceptual modeling framework was informed by two literature
reviews, qualitative research with modelers, including in-depth
interviews, observation of modeling practice and focus groups with
key experts, and a pilot study. The literature reviews aimed to 1)
describe the key challenges in public health economic modeling and
2) review conceptual modeling frameworks in the broader modeling
literature. The qualitative research aimed to understand the expe-
riences of modelers when developing public health economic model
structures and their views about the barriers and beneﬁts of using a
conceptual modeling framework. These are each described brieﬂy
here, although a more detailed description of the methods is
available in the doctoral thesis by Squires [8].Review of Key Challenges in Public Health Economic Modeling
An iterative search process was undertaken to identify literature
describing the key challenges in public health economic evalua-
tion. Articles relating to economic evaluation resulting from the
work of the Public Health Excellence Centre at the National
Institute for Health and Care Excellence (NICE) were identiﬁed
by searching for key people from the NICE website as authors in
MEDLINE, publications written by the Public Health Research
Consortium [9] were handsearched, and a MEDLINE search for
terms relating to problems in public health economic modeling
was undertaken. Key public health journals were subsequently
searched using search terms relating to economic evaluation.
The review included methodological articles on economic mod-
eling in public health. It excluded case studies of economic
evaluations, methods for valuing equity or health outcomes (as
against the incorporation of these in a model), and “gray liter-
ature” if the content was already published in a peer-reviewed
journal. After the initial searching process, additional targeted
searches were undertaken to develop more in-depth knowledge
about the key challenges identiﬁed from relevant discipline-
speciﬁc literature. Further details of this review are described in
a paper by Squires et al. [6].
Review of Existing Conceptual Modeling Frameworks
Existing conceptual modeling frameworks were identiﬁed via an
iterative search process following the NICE Technical Support
Document Guidance, including citation, reference, and key
author searching in MEDLINE, Scopus, and Web of Science in
2011 [10]. Three sets of search terms were combined with “AND”:
1) terms for conceptual models (limited to title with the aim of
ensuring that this is the main focus of the article); 2) terms for
quantitative models (to help to limit studies to those in which the
aim of the conceptual model is to develop a quantitative model);
and 3) terms for development (to help focus the search on
methods for the development of conceptual models rather than
on case studies reporting the output of a conceptual model).
Searches were not limited by discipline, study type, publication
date, or language. After article retrieval, the key characteristics of
the methods described in the articles were identiﬁed using a data
extraction form that was speciﬁcally developed for this review.
Qualitative Research
The qualitative research involved 1) tracking the development of
a speciﬁc public health economic model including observing key
meetings and undertaking in-depth interviews with the two
modelers involved; 2) systematically analyzing notes from a
previous modeling project assessing the cost-effectiveness of
interventions to encourage young people to use contraceptives;
and 3) holding a focus group meeting with modelers from ﬁve
different UK centers. The participants were identiﬁed purposively
for their varied experience in public health economic modeling
projects so that the views presented would be relevant, varied,
and comprehensive. Topic guides were developed for the inter-
views and the focus group, and the sessions were audio-recorded
and subsequently transcribed. The focus group aimed to capture
both agreement and disagreement between modelers. Analysis
involved copying each sentence of the transcripts and notes
systematically to an MS Excel (Microsoft) spreadsheet into emer-
gent categories, which were then grouped into themes. A reﬂex-
ive approach was taken (in which meaning was developed on the
basis of the complex relationship between the understanding of
the participants and the researchers before the research com-
bined with the additional meaning gained from the research),
and alternative meanings for each piece of data and opposing
views were actively considered.
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The literature reviews and qualitative research led to the devel-
opment of a wide range of speciﬁc requirements for a conceptual
modeling framework in public health economic evaluation (see
Appendix Table in Supplemental Materials found at http://dx.doi.
org/10.1016/j.jval.2016.02.011, which shows which method led to
each ﬁnding). On the basis of these, a draft version of the
conceptual modeling framework was developed. This was piloted
in a project funded by the National Institute for Health Research
School for Public Health assessing the cost-effectiveness of
interventions for diabetes screening and prevention [11] and its
use was critically reﬂected upon, which led to further improve-
ments to the framework.The Conceptual Modeling Framework
The conceptual modeling framework is underpinned by four key
principles of good practice in developing valid, credible, and
feasible models. These principles were derived from the two
literature reviews and the qualitative analysis and are described
in the next section, before the methodology of the framework is
presented. Detailed process suggestions and an example to
illustrate the methods on the basis of the diabetes prevention
pilot study are provided in Supplemental Materials found at
http://dx.doi.org/10.1016/j.jval.2016.02.011, although aspects of
the diabetes example are drawn upon throughout the article.
Key Principles of Good Practice
Four key principles of good practice emerged from a triangulation
of the methods described earlier: 1) a systems approach to public
health modeling should be taken; 2) a documented understand-
ing of the problem is imperative before and alongside developing
and justifying the model structure; 3) strong communication with
stakeholders and members of the team throughout model devel-
opment is essential; and 4) a systematic consideration of the
determinants of health is central to identifying key impacts of the
interventions in public health economic modeling. These are
each described here.
Key principle of good practice 1: A systems approach to public
health modeling should be taken
Public health economic modeling generally involves understand-
ing dynamically complex systems [12]. This means that these
systems are typically nonlinear in which the whole is not equal
to the sum of the parts. They are history-dependent; there is no
clear boundary around the system being analyzed, heterogeneity
and self-organization have an impact on the outcomes, and
people affected by public health interventions may learn and
adapt over time and change their behavior accordingly [13]. In
complex systems there may be positive feedback loops, whereby
if factor A increases [decreases], the number of factor B increases
[decreases], which leads to factor A increasing [decreasing]
further, which would lead to exponential growth [decay] if no
other factors were present [13]. For example, an increase in
obesity might lead to an increase in depression, which, in turn,
might lead to an increase in obesity, and so on. There may also be
negative feedback loops, in which an increase [decrease] in factor
A leads to an increase [decrease] in factor B, which, in turn, leads
to a decrease [increase] in factor A [11]. For example, an increase
in eating will lead to an increase in weight gain (all other things
being equal), which may lead to a decrease in eating. When both
positive and negative feedback loops exist in a system, this may
produce counterintuitive behavior, often occurring over a long
period of time [13]. In these dynamically complex systems,factors are constantly changing over time, and a sudden mod-
iﬁcation in behavior may arise as a result of a number of smaller
heterogeneous changes. Taking action in such a system on the
basis of simple cause and effect may lead to unexpected and
unwanted outcomes.
A systems approach, or systems thinking, is suited to model-
ing these dynamically complex public health systems. It is a
holistic way of thinking about the interactions between parts in a
system and with its environment [14]. In systems thinking there
are multiple system levels, whereby the system of interest is
subjectively deﬁned and there is always a higher level system in
which it belongs and a lower level system that describes detailed
aspects. The challenge in health economic modeling is to deter-
mine which level will represent that of the system of interest (the
model), by demonstrating sufﬁcient knowledge about the higher
level system (the broader understanding of the problem), and
subsequently deﬁning an appropriate level of detail for the
system of interest. In systems thinking, the importance of not
considering one aspect of a system in isolation is emphasized to
avoid ignoring unintended consequences. In addition, the culture
and politics of the system cannot be ignored because these will
affect the process by which decisions are made and the objectives
of stakeholders and the environment they operate in, as recog-
nized by soft systems methodology [15].
Key principle of good practice 2: A documented understanding of
the problem is imperative before and alongside developing and
justifying the model structure to develop valid, credible, and
feasible models
It is valuable to have an initial understanding of the problem and
to document this understanding before making simpliﬁcations
when developing the model structure for both theoretical and
practical reasons. Theoretically, it provides a basis for validation
by facilitating the speciﬁcation of an appropriate model scope
and transparent structural assumptions, and for increasing
credibility by supporting stakeholder involvement and producing
clear documentation throughout the development of the model
structure [3]. We learn by building upon what we already know,
and our vision of the world or construction of a problem is
constrained by our previous “knowledge” [16]. As such, if a model
is data-led and/or based on only the analyst’s interpretation of
the data, it may lead to a narrow view of what should be included
in the model. Documenting an understanding of the problem
before analyzing available data sets allows that understanding to
be reﬂected upon and shared. This reduces the risk of ignoring
something that may be important to the model outcomes, which
may be particularly important given the likely dynamic complex-
ity of the system. In terms of systems thinking (see key principle
of good practice 1), documenting an understanding of the prob-
lem (the higher level system) allows the modeler to be able to
deﬁne the boundary of the system of interest for modeling. This
description of the understanding of the problem should also help
the modeler to understand the impact of potential simplifying
assumptions they might use in the model.
Practically, if the problem is not sufﬁciently understood, an
inappropriate model structure may be developed which may be
inefﬁcient to correct in the computer software retrospectively,
particularly if an alternative model type needs to be developed
(e.g., a discrete event simulation rather than a Markov model).
Thus, taking time at the beginning of the project to understand
the problem could reduce overall time requirements. Document-
ing the understanding of the problem also enables communica-
tion with stakeholders and the project team (see key principle of
good practice 3). An additional beneﬁt is that the documentation
of the understanding of the problem could be used (alongside any
logic models developed) to help stakeholders understand
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understanding of the problem will enable researchers and policy-
makers who are not involved in the project to understand the
problem and the basis for decisions about the model structure.
Thus, as also proposed by Roberts et al. [7] and Kaltenthaler
et al. [17] in the context of clinical economic modeling, it is
recommended that the model structure be developed in two
phases. The ﬁrst is to develop an understanding of the decision
problem that is sufﬁciently formed to tackle the aforementioned
theoretical and practical issues; this exercise should not be
limited by the empirical evidence available. The second is to
specify a model structure for the decision problem that is feasible
within the constraints of the decision-making process. The
understanding of the problem will inevitably continue to form
during model development; this initial documented understand-
ing, however, provides a basis for comparison and any major
changes to this understanding can subsequently be documented.Key principle of good practice 3: Strong communication with
stakeholders and members of the team throughout model
development is essential for model transparency, validity, and
credibility
The literature suggests that stakeholders can encourage learning
about the problem (including geographical variation of health
care provision and stakeholders’ values and preferences), help to
develop appropriate model objectives and requirements, facili-
tate model veriﬁcation and validation, help to develop credibility
and conﬁdence in the model and its results, guide model devel-
opment and experimentation, encourage creativity in ﬁnding a
solution, and facilitate model reuse [7, 17–22]. In addition, stake-
holders can help to deﬁne the meaning of subject-speciﬁc
terminology, which has a different lay meaning. Pidd [1] has
used the metaphor of taking a photograph of a scene, whereby
each person involved might see different aspects of the scene
and frame the photo differently. The more frames provided by
people with different interests, the better the discussion regard-
ing the perspectives and the richer our understanding.
The modeler should question the assumptions of the stake-
holders [23] and the project team throughout the model develop-
ment process to uncover inconsistent, biased, and invalid
assumptions. In topics for which the project team has existingFig. 1 – Determinants of health by Dahlgren and“knowledge,” it is important to be aware of the tendency to
anchor to initial beliefs and be open to new theories to develop
valid models [14, 24]. Effective ways of communicating informa-
tion, such as using clear diagrams, should be used to share
information and describe assumptions.
Key principle of good practice 4: A systematic consideration of
the determinants of health is central to identifying key impacts
of the interventions in public health economic modeling
The determinants of health that include the social, economic,
and physical environment, as well as a person’s individual
characteristics, are central to the consideration of public health
interventions. There are a large number of classiﬁcations of the
determinants of health; many of them, however, comprise
similar factors. Perhaps the most well-known is that of Dahlgren
and Whitehead [25], shown in Figure 1, which shows individual-,
community-, and population-level factors that impact on and are
impacted by health. Individual behaviors (such as buying certain
food) impact on the social determinants of health (such as social
class and access to amenities), which, in turn, impact on
individual behaviors [26]. Thus, it is important to consider
broader determinants of health to predict the full impact of
interventions on health outcomes. In addition, classiﬁcations of
the determinants of health could be used to facilitate identiﬁca-
tion of nonhealth costs and outcomes associated with the
interventions, such as those in transport or employment, and
of potential intervention types to assess in the model. This
includes those that might impact on individual health through
making community- and population-level changes, such as food
production, as well as those that might impact on health through
changing individual lifestyle factors. Similarly, subpopulations
that might beneﬁt from the intervention could be identiﬁed, for
example, low-income areas where there are high levels of
unemployment and lack of education. Finally, the consideration
of social network effects could affect the analytical model type
chosen, and subsequently the predicted impact of the interven-
tions. It is unlikely to be appropriate or feasible to include all the
determinants of health in a model; nevertheless, they should be
systematically reﬂected upon during the understanding of the
problem phase to consider which determinants it might be
important to include in the model so that all important mecha-
nisms and outcomes of the interventions can be captured.Whitehead [25] (reproduced with permission).
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The conceptual modeling framework consists of four key phases:
Phase A: Aligning the framework with the decision-making process;
Phase B: Identifying relevant stakeholders; Phase C: Understanding
the problem; and Phase D: Developing and justifying the model
structure (as shown in Fig. 2). The entire model development
process is inherently iterative, as shown by the arrows in
Figure 2. Evidence identiﬁcation is not described as a separate
activity (apart from reviewing existing models) because it is
required in most of the outlined stages. Iterations, however, are
inevitable between appropriate conceptualization and data collec-
tion because there is unlikely to be the exact evidence available that
has been speciﬁed by the conceptual model. Each stage of the
conceptual modeling framework is described here.
Phase A: Aligning the framework with the decision-making process
The conceptual modeling framework is intended to be applicable
across different decision-making contexts, which means that
decisions about how to use the framework in a speciﬁc process
are required. For example, the project team may need to operate
differently according to the nature of the engagement with
decision makers (people whom the model supports) and clients
(people who sponsor the modeling) in the project. Key decisions
during this phase relate to the relevant modes of stakeholder
engagement, the approach to evidence searching, and the time
and resources available for the modeling project and each stage
of the framework. A deliverable of this phase may be a protocol
document outlining the project plan with headings for each stage
in the conceptual modeling framework, including detailed project
time scales. This document can be used as a basis for discussion
between the project team and the stakeholders and should be
approved by the client. This helps the clients to understandA) Aligning the framework with 
the decision making process
C) Understanding
i) Developing a conceptual model of the problem
relationships and mode
ii) Describing current r
D) Developing and justifyin
i) Reviewing existing ec
ii) Choosing specific m
iii) Determining the m
iv) Determining the 
v) Choosing the 
vi) Developing a qualitative descrip
Fig. 2 – Overview of conceptual modeling framewwhether the project is planned to run appropriately and the
project team in ensuring feasibility of the project.
Phase B: Identifying relevant stakeholders
There are a number of different types of stakeholders, deﬁned as
any person who impacts on or is impacted upon in the system, in
any public health project. The choice of stakeholders involved
with the development of the model will inevitably affect the
model developed and the interventions assessed. For instance,
stakeholders help deﬁne the model scope, make value judg-
ments, use their expertise to recommend structural assumptions
such as extrapolating short-term trial data over the long-term,
and choose which interventions to assess in the model. In some
projects, the stakeholders who inform the model development
are chosen by the modeling team, whereas in other projects a
group of experts is chosen by a decision-making body, such as in
the NICE process (see phase A). There is, however, usually the
opportunity to involve additional experts chosen by the project
team, which is useful for providing alternative perspectives.
On the basis of soft systems methodology [15] and a con-
ceptual modeling article by Roberts et al. [7], the types of stake-
holders to involve are as follows:1.B
 th
 de
lling
eso
g t
ono
ode
od
lev
mo
tion
orCustomers of the interventions, including patient representa-
tives and lay members;2. Actors in the system, including clinical and epidemiologic
experts for all relevant diseases and methods experts; and3. System owners, that is, those with the power to stop public
health activity (including problem owners).
The relationships between the customers, actors, and system
owners can be considered to identify relevant stakeholders. For) Identifying relevant 
stakeholders
e problem
scribing hypothesized causal   
 objectives
urce pathways
he model structure
mic evaluations
l interventions
el boundary
el of detail
del type
 of the quantitative model
k for public health economic modeling.
V A L U E I N H E A L T H 1 9 ( 2 0 1 6 ) 5 8 8 – 6 0 1 593the diabetes example, if a general practitioner (actor) has been
identiﬁed as a stakeholder, this could help identify the patient
(customer). The person with the power to stop the actor giving
the customer a service might be the local commissioner (system
owner). A table of stakeholders and their roles could be included
in the report/appendices (see diabetes example in Supplemental
Materials found at http://dx.doi.org/10.1016/j.jval.2016.02.011).
Stakeholders should be involved during the understanding of
the problem phase and the development and justiﬁcation of the
model structure phase. If time and resources allow, this could be
through a series of workshops, although modelers should be
aware that these are subject to their own dynamics. Practically,
the approach to stakeholder communication needs to be ﬂexible.
We discuss stakeholder involvement further in phases C and D.
Phase C: Understanding the problem
The whole of phase C is about problem formulation rather than
model formulation. Developing and documenting an understand-
ing of the problem is at the core of being able to develop an
appropriate model structure (see key principle of good practice 3).
This is about understanding what is relevant to the problem, and
should not be limited by what empirical evidence is available [17].
The understanding of the problem phase in Figure 2 comprises 1)
developing a conceptual model of the problem describing
hypothesized causal relationships (as described in steps 1–4),
including specifying a clear research question, and 2) describing
present resource pathways. A diagram depicting the understand-
ing of the problem (see Fig. 3 for an illustrative example) and a
diagram showing key resource use in the system, both with
accompanying notes, can be included in a report. An example of
the development of these diagrams using the diabetes pilot study
is shown in Supplemental Materials found at http://dx.doi.org/10.
1016/j.jval.2016.02.011.
Developing a conceptual model of the problem describing
hypothesized causal relationships. This section outlines a meth-
odology for developing a conceptual model of the problem by
using the notation of causal diagrams, borrowing some of the
methods from cognitive mapping [27], and ensuring that the
worldview of each of the stakeholders is considered [15, 27]. This
methodology provides a systematic approach for developing an
understanding of the problem at an appropriate and manageable
level of relevance. A causal diagram depicts the relationships
between factors by arrows, using a “þ” or “–” sign to indicate a
positive or a negative causal relationship. Causal diagrams allow
feedback loops to be described that depict the dynamic complex-
ity of the system. Each factor is a quantity such that one factor
leads to an increase or decrease in another factor. For example,
CVD event-
þ
Cost and CVD event-

Quality of life
means an increase in cardiovascular disease (CVD) events leads
to an increase in costs and a decrease in quality of life,
respectively. The hypothesized causal relationships associated
with the problem can be depicted using this notation, bringing
together the understanding of relevant diseases, human behav-
ior, and societal inﬂuences.
Step 1: What is the problem?. The ﬁrst step, on the basis of
cognitive mapping [27], is to ask “What is the problem?” This is
the key problem from the decision makers’ perspective and could
be based on the project scope if available. The cause of the
problem described should include a potentially modiﬁable com-
ponent. Describing the key problem as the starting point encour-
ages a focused boundary around the understanding of the
problem.Step 2: Why is this a problem?. The modeler can then ask “Why
is this a problem?” and continue to ask “Why?” or “What are the
implications of this?” until no more factors are identiﬁed, again
on the basis of the methods of cognitive mapping [27]. The goal
may be to maximize net beneﬁts by maximizing health and
minimizing costs, or equity may be considered of primary
importance, as is often the case in public health [28].
Step 3: Developing additional causal links. A set of questions
that may help develop the diagram further has been constructed,
as given in Table 1. The development of the understanding of the
problem is iterative, and hence it may be useful to continually
revisit these questions. The meaning of topic-speciﬁc terminol-
ogy should be clearly described.
Step 4: Incorporating types of intervention. In dynamically
complex systems such as public health systems, the possible
types of interventions may not be easily deﬁnable at the start of
the project before developing a sufﬁcient understanding of the
problem. Thus, the modeler can ask how to avoid or reduce the
impact of the described problem. It is useful to know what is
considered to be the present practice. Potential types of inter-
ventions can then be added on the basis of the project scope, any
effectiveness studies identiﬁed, and by considering in the dia-
gram when interventions may be beneﬁcial. One way of doing
this is to consider which of the potentially modiﬁable determi-
nants of health (individual lifestyle factors; living and working
conditions and access to essential goods; and general socio-
economic, cultural, and environmental conditions) affect the
decision problem. Combinations of individual, community, and
population interventions may be considered because simultane-
ous implementation is likely to be most effective [29]. It is not
expected that the ﬁnal interventions being assessed in the model
will have been chosen at this stage. It is, however, important to
deﬁne the types of interventions that might be assessed in the
model so that their impact on model factors, including those not
already incorporated into the diagram, may be considered.
A set of questions that may be useful for considering the
impacts of the interventions has been constructed, as given in
Table 2. These should be considered in the context of each type of
intervention potentially assessed in the model.
The research question. A research question should be agreed
upon and clearly speciﬁed during the development of the under-
standing of the problem, and may comprise the types of inter-
ventions being assessed, their outcomes, and the population(s) of
interest. For example, “What is the effectiveness and cost-
effectiveness of intervention x which might decrease outcome y
in population z?” The research question should be regularly
referred to during the design-oriented conceptual modeling phase
(see phase D) so that the model is built for purpose. In addition, as
Roberts et al. [7] suggest, the policy context of the modeling project
needs to be clear, particularly in terms of the funder, the policy
audience, and whether the model is planned to be for single or
multiple use.
Sources of evidence. The proposed diagram can provide an explicit
description of our hypotheses about causal relationships and the
challenge is to be able to justify the causal assumptions made. The
causal hypotheses can be developed on the basis of a range of
sources including the project scope, literature (which may involve
perspectives from several disciplines including considering existing
models in biology, psychology, sociology, and behavioral econom-
ics), stakeholder input, the team’s previous work, and any other
diagrams developed by the project team or decision makers to
F
F
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V A L U E I N H E A L T H 1 9 ( 2 0 1 6 ) 5 8 8 – 6 0 1594depict their understanding of the problem. By developing the
diagram with input from stakeholders, it allows their assumptions
and beliefs to be made explicit so that they can be agreed upon or
questioned. Developing the diagram using all these sources ofig. 3 – Example conceptual model of the problem (with interventi
PG, fasting plasma glucose; HbA1c, glycated hemoglobin A1c; IGR
GTT, oral glucose tolerance test; PSS, Personal Social Services; Qevidence will be an iterative process, providing multiple opportu-
nities to question and adapt the causal assumptions.
An illustrative example of a conceptual model of the problem
for the diabetes pilot project is shown in Figure 3.ons). BGL, blood glucose level; CVD, cardiovascular disease;
, impaired glucose regulation; NHS, National Health Service;
ALYs, quality-adjusted life-years.
Table 2 – Questions about the interventions and
their impacts.
1. Questions relating to the constraints of the decision-making process:
 Are there constraints on the project scope? (e.g., Are we
constrained by the types of interventions we are assessing? What
about the population?)
2. Questions relating to the goals and mechanisms associated with the
interventions:
 What are all the outcomes (positive and negative) of the
interventions?
 What would happen in the absence of the interventions vs. as a
result of the interventions—would outcomes be prevented or
delayed?
 What evidence exists to describe the outcomes of the
intervention/comparator over time? Are behavioral outcomes
important? If so, do any relevant models of behavior from
psychology, sociology, or behavioral economics exist to help
describe the behavior resulting from the intervention or the
comparator? This will require additional targeted literature
searches.
 Are there any determinants of health reported by the
effectiveness studies that are not included in the causal diagram?
Can such a relationship be described?
3. Questions relating to the dynamic complexity of the system:
 Might a third party act to reduce the impact of interventions?
 Are there any substantial impacts of social and/or community
networks on intervention effectiveness? Will these impacts be
captured over the long term in the effectiveness evidence?
 Are there any substantial impacts of the interventions on other
lifestyle factors?
 Might the interventions have other impacts not already
considered?
Table 1 – Questions about the decision problem to
help with developing the diagram.
1. Questions relating to the disease and the determinants of health:
 Have any relevant disease natural histories been captured?
 Are the following determinants of health (taken from the study by
Dahlgren and Whitehead [25]) important in determining effects
and in what way?
– Age, sex, and other inherent characteristics of the population
of interest
– Individual lifestyle factors (including diet, physical activity,
smoking, alcohol/drug misuse)
– Social and community networks (including friends, family
including intergenerational impacts, wider social circles)
– Living and working conditions and access to essential goods
and services (including unemployment, work environment,
agriculture and food production, education, water and
sanitation, health care services, housing)
– General socioeconomic, cultural, and environmental
conditions (including economic activity, government policies,
climate, built environment including transportation, crime)
2. Question to help ensure that the understanding of the problem is
sufﬁciently broad:
 Are there any other (positive or negative) consequences of each
factor?
3. Questions to ensure that the dynamic complexity of the system has
been captured:
 Could there be any other factors that explain two outcomes, for
links that may not be causal, but correlated?
 Are there any other possible causal links between the factors?
(with the aim of establishing whether there are any
feedback loops)
 Are there interactions between people that affect outcomes? (see
social networks earlier)
 Is timing/ordering of events important?
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resource use at this stage is not necessary because some factors
in the conceptual model of the problem will be excluded from the
quantitative model. Nevertheless, a broad consideration of
resource use at this stage may help the modeler choose which
factors to include and exclude from the model when choosing the
model boundary (see phase D, “Determining the model boun-
dary” section). For example, a factor that is unlikely to affect the
model results substantially on the effect side but requires sub-
stantial resources may be included, whereas one that is also
unlikely to substantially impact on the cost side may be excluded.
Practically, it is useful to begin to establish resource use with
stakeholders at this early stage because this usually requires
several iterations. Flow diagrams, tables, and/or a textual descrip-
tion of the resource pathways can be useful.Phase D: Developing and justifying the model structure
This section aims to outline an approach for specifying an
appropriate model structure that is feasible, valid, and credible
to develop into a quantitative model, which may be described as
the design-oriented conceptual modeling phase [17]. As outlined
in Figure 2, this phase includes 1) reviewing existing health
economic models; 2) choosing model interventions and compa-
rators; 3) determining the model boundary (deciding what factors
are included in the model rather than being part of its external
environment); 4) determining the level of detail (the breakdown
of what is included for each factor in the model boundary and
how the relationships between factors are deﬁned); 5) choosingthe model type (the analytic modeling technique used, e.g., a
Markov model); and 6) developing a qualitative description of the
quantitative model. A method for each of these stages is sub-
sequently described. Documenting each of these stages aids in
transparency and model veriﬁcation, validation, and reuse, and
suggested ways of doing this are described. As for the under-
standing of the problem phase, a practical example is shown for
the diabetes pilot study in Supplemental Materials found at
http://dx.doi.org/10.1016/j.jval.2016.02.011. The understanding of
the problem, the review of existing economic evaluations, and
the review of intervention effectiveness can be used to facilitate
decisions around the model boundary, level of detail, and model
type, as shown in Figure 4. This ﬁgure provides the linkages
between each stage. The subsequent sections then provide more
detail about how each stage informs the other.
Reviewing existing health economic models. It is standard prac-
tice in health economic evaluation to undertake a systematic
review of existing health economic models in the same area [30,
31]. Some existing models may have been used to develop the
understanding of the problem, but a systematic review of models
at this stage can be used in a number of ways [32]:1. To compare and contrast how other modelers have chosen to
structure the model and estimate key variables, and how the
model results differ on the basis of these choices;2. To identify which variables are important in inﬂuencing
model results (including any that have not been highlighted
during the understanding of the problem phase) and which do
not substantially affect the differences in outcomes between
the interventions and comparators;
Develop understanding of the 
problem
Assess whether there is 
an exisng model which 
could be employed
Idenfy strengths & 
limitaons of diﬀerent 
model structures
Idenfy strengths & 
limitaons of diﬀerent 
model types
Idenfy key variables which 
generally aﬀect model results 
(incl. any not already 
idenﬁed) & key variables 
included within the causal 
diagram which do not
Idenfy the sort 
of data available
Idenfy types of 
outcomes reported
Idenfy long term 
evidence & mechanisms
Describe eﬀecveness of  
intervenons (to help 
choose which to model 
& for parameterizaon)
Model boundary Model detail Model type
Discuss potenal model perspecves, 
outcomes, intervenons & 
populaons with stakeholders
Review exisng health 
economic models
Review eﬀecveness of 
relevant intervenons
Review evidence of 
relaonships between 
factors
Idenfy factors with not many 
causal links & assess whether they 
would have a substanal impact 
upon the diﬀerence between 
outcomes of intervenons & 
comparators
Fig. 4 – Deﬁning the model boundary, level of detail, and model type.
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inform the model level of detail;4. To consider the strengths and limitations of existing eco-
nomic evaluations, to inform model development;5. To determine whether there is an existing model that could be
used, either in part or as a whole.
Choosing model interventions and comparators. The decision
makers (with consideration of the clients’ needs if they are not
the decision makers) should deﬁne which speciﬁc interventions
to model, with reference to the intervention effectiveness evi-
dence, and according to expertise from other stakeholders. The
decision makers may limit interventions to be assessed on the
basis of the evidence available, including relevant populations,
outcomes, and potential biases in the trials. It is possible that one
good study or a number of studies can be used to estimate the
short-term effectiveness. As far as possible, the comparator can
be based on the same studies as the interventions if this is
representative in practice. If practice is substantially different,
then an adjustment on the effectiveness estimate would be
required. Context is important for the effectiveness of public
health interventions. Given that economic evaluation is a com-
parative analysis, the model results are meaningful only in
relation to the comparators chosen [7].
Determining the model boundary. Determining the model boun-
dary is about deciding, on the basis of the understanding of the
problem, what factors should be judged as relevant for inclusion
in the model and which can be excluded given the time and
resource constraints of the decision-making process. The boun-
dary of the model must differ from the boundary of the under-
standing of the problem to be able to make informed judgmentsabout what is important to include in the model structure. The
model boundary should be deﬁned such that all important
interactions between the elements of the system identiﬁed in
the understanding of the problem are captured [23].
Model population and subgroups. The model populations can be
discussed with the stakeholders, informed by the populations in
the intervention effectiveness evidence. The modeling team and
the stakeholders could consider whether there is a bigger prob-
lem in a particular subgroup or whether the intervention is likely
to be more effective in a particular subgroup and whether there is
sufﬁcient data to undertake any subgroup analysis. These might
be based on the determinants of health shown in Figure 1,
including age, sex, and other inherent characteristics of the
population of interest, individual lifestyle factors, living and
working conditions and access to essential goods, and general
socioeconomic, cultural, and environmental conditions.
Model perspectives and outcomes. Often in health economic
evaluation, a health sector perspective is used [30]. Never-
theless, in public health economic modeling, other perspec-
tives are likely to be relevant because substantial costs and
beneﬁts may extend beyond these sectors. Alternative perspec-
tives include (but are not limited to) a societal perspective, a
public sector perspective, or the perspective of the particular
agencies involved in the system. Of particular importance will
be the perspectives of the system owners identiﬁed in phase B
of the framework. For example, if employers are considered to
be system owners, then an employer perspective would be
useful. It should be noted that there are at present unresolved
issues around using these alternative perspectives in terms of
1) whether it is possible or desirable to make social value
judgments associated with the value of health relative to the
1) Consider what is theorecally appropriate and what is required under a reference case if 
applicable for (a) perspecves and (b) outcomes. 
When considering (b) model outcomes, how do the model perspecves aﬀect this? 
2)    Consider by whom the results of the research will be used to consider whether addional (a) 
perspecves and (b) outcomes may be useful.
3)    Discuss with stakeholders those perspecves and outcomes idenﬁed within (1) and (2) and 
ask if there are any addional (a) perspecves and (b) outcomes that it might be useful to consider.
Fig. 5 – Method for choosing appropriate modeling perspectives and outcomes.
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transferring costs and beneﬁts between sectors [33]. Nonethe-
less, if substantial costs and beneﬁts are expected to fall
outside of the National Health Service and the Personal Social
Services (PSS), presenting these alternative perspectives is
likely to be informative for decision makers.
To be able to compare interventions across different popula-
tions in terms of health costs and outcomes, the incremental cost
per quality-adjusted life-year may be used [34]. When the model
boundary extends beyond health, it may be useful to understand
the modeling requirements in other sectors so that relevant
outcomes may be presented. A cost-beneﬁt analysis may be
considered theoretically superior given the scope of public health
interventions and outcomes [35]; nevertheless, there are at
present practical issues associated with monetary valuation of
outcomes. One way of presenting multiple outcomes for different
sectors is to present a cost-consequence analysis alongside the
cost-effectiveness analysis [36–38]. A method for choosing model
outcomes and perspectives has been outlined in Figure 5.
Other model boundary considerations. An algorithm to help
deﬁne the model boundary is shown in Figure 6 and can be
considered for each factor in the conceptual model of the
problem. In Figure 6, the question “Does the factor have many
causal links?” aims to identify which factors are central and
should be included in the model, even in the absence of data (lots
of links), and which factors are less important (not many links to
other factors). Formal approaches for assessing importance or
centrality in extensive causal chains are available and imple-
mented in computer software [27]. The question of whether the
impact of a factor is substantially captured by other factors
attempts to exclude any double counting.
Subsequent questions in Figure 6 encourage the modeler to
think about whether it is worthwhile including noncentral factors
given the expected results of the model and the anticipated
direction of effect of the factor on those results, as well as the
differential impacts of the interventions on that factor. If differ-
ent interventions impact on the factor through different mech-
anisms, then including or excluding the factor may lead to
different incremental analysis conclusions. The question in
Figure 6 about whether the factor is likely to have a substantial
impact on the difference between costs and effects of the
interventions entails having an understanding of the magnitude
of the cost and outcomes associated with the factor and the
extent to which the interventions might change these. Such
subjective judgments will inevitably be considered in the contextof the time available for modeling and the potential future uses of
the model. The model boundary stage, however, should not be
overly dependent on the evidence or time available because this
can be accommodated by the level of detail incorporated. It is
likely to be more appropriate to crudely include a factor that is
expected to substantially affect the model results than to exclude
it from the model completely. Finally, to maintain model credi-
bility, stakeholders can be asked whether they are happy, given
these justiﬁcations, with the exclusion of factors. One way of
reporting this stage is to produce a table stating whether each
factor is included or excluded and the justiﬁcation for exclusion,
as suggested by Robinson [39].Determining the level of detail. The level of detail is deﬁned as the
breakdown of what is included for each factor in the model
boundary and how the relationships between factors are deﬁned.
A decision about which parts of the model are likely to beneﬁt
from a more detailed analysis can be made a priori to avoid
situations in which the modeler focuses on speciﬁc parts of the
model because they are more easily dealt with and subsequently
run out of time to develop other parts in detail. Essentially, the
modelers can weigh up, on the basis of the documented under-
standing of the problem and the deﬁned model boundary,
whether the time required to do one analysis at a speciﬁc level
of detail in the model is likely to have more of an impact on the
model results compared with comparative time spent on other
analyses, given the present evidence available and the overall
time constraints. During model analysis, more detail can be
incorporated if part of the model is shown to substantially affect
the results. Table 3 summarizes key questions for the modeler to
help choose an appropriate level of detail.Searching for evidence. Data for inclusion for specifying the
model structure and its parameters will need to be identiﬁed at
this point if they have not been already. This could be based on
literature identiﬁed during the development of the conceptual
model of the problem for which speciﬁc literature was noted as
useful, although additional speciﬁc searches may also be
required. Data collection and the development of a description
of the level of detail for the model will be a highly iterative
process. Sufﬁcient evidence is required to be able to justify why
the modeling choices have been made [10]. It is important to note
that elements for which there is a lack of empirical data and
which are considered to have key differential impacts on the
comparator(s) and the intervention(s) may be informed by expert
Does the factor have many causal links?
Yes No
Is the factor likely to have a substanal 
impact upon the diﬀerence between costs & 
eﬀects of the intervenons? This may be 
based upon (though not limited to): 
(1) the review of economic evaluaons;
(2) the descripon of resource pathways;
(3) clinical papers describing the causal links;
(4) exisng models in similar areas which 
describe the impact of the factor;
(5) methodological choices eg. discounng;
(6) expert advice.
Yes No
INCLUDE
Is the factor associated with the intervenons, 
populaons & outcomes being modelled? 
EXCLUDE
INCLUDE
EXCLUDE
Yes No
Yes
Is the impact of the factor predominantly 
captured by other included factors?
Yes
EXCLUDE
No
Would stakeholders prefer to 
include the factor for model 
credibility AND is it relavely easy 
to incorporate in terms of 
modelling skill & data availability?
INCLUDE
No
Are all intervenons likely to be cost saving/ have a low ICER 
AND does the factor further increase beneﬁts/ decrease costs 
AND do all intervenons aﬀect the factor in the same way? 
Yes
No
To be considered in the context of the me available for modelling & potenal model reuse
Fig. 6 – Deﬁning the model boundary. ICER, incremental cost-effectiveness ratio.
V A L U E I N H E A L T H 1 9 ( 2 0 1 6 ) 5 8 8 – 6 0 1598elicitation. One consideration at this stage is likely to be the
derivation of the disease natural history parameters, which may
be taken from existing studies or calibrated using statistical
methods.Expressing structural uncertainty. It is likely to be preferable to
limit the development of different model structures in policy
analysis, and conceptual modeling can be used to do so. Never-
theless, when there is more than one plausible assumption that
Table 3 – Questions to help in making judgments
about the model level of detail.
1. General question:
 Is the time required to do the analysis at a speciﬁc level of detail
likely to have more of an impact on the model results than the
same time period spent on other analyses, given the evidence
available and the overall time constraints?
2. Questions to describe the relationship between the included factors over
time:
 What outcomes are reported in the review of intervention
effectiveness? (to help choose which causal links to include)
 What evidence is available to model the causal links and the
outcomes of the factor? (to avoid relying on the ﬁrst available
evidence)
 What do other economic evaluations suggest are the strengths
and limitations of different mathematical relationships between
model factors?
 Which determinants of health are key drivers of the problem
according to relevant theory?
3. Questions to help extrapolate study outcomes:
 What outcomes are reported in the review of intervention
effectiveness?
 What evidence is available for long-term follow-up?
 Is there sufﬁcient evidence and time available to model social
networks given the expected impact on model results (on the
basis of the understanding of the problem)?
4. Questions about the level of detail used to describe each included factor:
 Which are the speciﬁc aspects of each factor that are likely to have
a substantial impact on the model results?
– Is all costly resource use captured?
– Are all substantial health beneﬁts and disbeneﬁts captured
using measures acceptable to the decision maker given the
available evidence?
 Are impacts included in both costs and beneﬁts where
appropriate?
5. Questions about how interventions will be implemented in practice:
 What do the effectiveness studies describe?
 What do stakeholders suggest would happen in practice and is
this likely to lead to different estimates of effectiveness to those in
the study?
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develop model structures for each assumption to undertake
posterior analysis of structural uncertainty, for example, model
averaging. This would be undertaken by creating a parameter to be
included in the PSA to represent the probability of each structure
being appropriate. This parameter and its distribution could then be
estimated by elicitation with experts [40].Reporting level of detail. A document can be developed that
describes and explains the key model simpliﬁcations and
assumptions for discussion with stakeholders, ideally during a
second workshop. Writing these down with justiﬁcation provides
a mechanism for systematically questioning the simpliﬁcations
and assumptions with stakeholders and the project team to
improve model validity and credibility. It also facilitates the
development of models in future projects. The level of detail will
be affected by the model type chosen, and hence it will be an
iterative process between identifying an appropriate level of
detail and choosing the model type.Choosing the model type
Most appropriate model type given the characteristics of the
problem. It is important to understand the most appropriate
method given the characteristics of the problem, even if it is not
practical to develop this model type, so that the simpliﬁcations
being made are clear. A number of existing articles outline
taxonomies for deciding on appropriate model types given the
characteristics of the problem for health economic modeling
[41–43]. Although decision trees and Markov models are most
often used when modeling clinical interventions [42], because of
the complexity associated with public health systems it is likely
that alternative model types may be more appropriate. Agent-
based simulation (ABS) is not included in existing taxonomies; it
may, however, be useful for modeling dynamically complex
public health systems. ABS is a bottom-up approach in which
the behavior of the system is a result of the deﬁned behavior
(based on a set of rules) of individual agents and their interac-
tions in the system [44]. Thus, ABS may be preferable when the
interactions between heterogeneous agents and their environ-
ment are important. ABS more easily allows the analyst to
capture spatial aspects to model appropriate interactions (e.g.,
family and friend networks for transmission of a contagious
disease) [44]. Studies have shown strong social network impacts
of behaviors such as dietary habits [45].
Most appropriate model type on the basis of broader consid-
erations. It may not always be practical to use the model type
that is most appropriate for the characteristics of the problem.
Figure 7 provides an outline of how the modeler might decide on
the most appropriate model type according to broader practical
issues.
Qualitative description of the quantitative model. A qualitative
diagram of the quantitative model alongside the development of
the model structure can facilitate clear communication of the
ﬁnal model structure to stakeholders, other members of the
team, and people who may want to understand the model in
the future. Standard diagrams associated with each model type
can be developed. Although the design-oriented conceptual
modeling can be described before the quantitative model devel-
opment, it may be iteratively revised according to data avail-
ability and/or inconsistencies identiﬁed during the development
of the quantitative model [17,19,20,39]. These modiﬁcations
should be documented throughout so that there is transparent
justiﬁcation for the ﬁnal model developed.Discussion and Conclusions
A conceptual modeling framework has been developed as a
helpful tool for modelers of public health economic models.
The recent development of two conceptual modeling frameworks
for assessing the cost-effectiveness of clinical interventions high-
lights the importance and timely nature of this work [7, 17]. The
conceptual modeling framework developed here complements
and adds to these existing frameworks by focusing on public
health economic modeling and providing practical approaches
for the modeler to follow throughout the conceptual modeling
process. The main contribution of this research is that it draws
upon several disciplines to provide a systematic approach for
developing public health model structures and, in particular,
systematic consideration of:
Determine the most appropriate model type for the characteriscs of the problem (see above).
Is this feasible within the me and resource constraints of the decision making process given:
(i) the data available?
AND
(ii) the accessibility of any exisng relevant good quality economic evaluaons for use as a starng point? 
AND
(iii) the experse of the modeller?
Are you intending to use the model 
again for other projects?
Can you answer the queson with a few 
provisos with a simpler model type, given 
your understanding of the problem?
Yes No
Explore with the 
decision maker the 
most useful purpose of 
the modelling given 
the project constraints
Develop the simpler 
model type, documenng 
the provisos, uncertaines
& implicaons of the 
simpliﬁcaons
NoYes
Do you think a simpler model 
type would lead to the same 
conclusions, given your 
understanding of the problem?
Develop 
the 
model
Yes No
Develop the more 
complex model
Develop the simpler model,  
documenng the provisos, 
uncertaines & implicaons 
of the simpliﬁcaons
Yes No
Fig. 7 – Choosing the model structure.
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2. the dynamic complexity (feedback loops, unintended
consequences);
3. the understanding of the problem;
4. moving from an understanding of the problem to the model
structure; and
5. stakeholder involvement.
The aim of this systematic approach is to help to improve the
quality of public health economic models to support the efﬁcient
allocation of scarce resources and contribute to improved health
and well-being.
The use of the conceptual modeling framework requires a
shift in the way some modelers who are used to developing
models of clinical interventions approach decision problems,
both in terms of the planning and reporting process and the
consideration of the broader determinants of health and
dynamic complexity. This shift is essential if model develop-
ment in public health economic evaluation is to be improved.
There are typically time constraints around the decision-
making process, and an important practical consideration is
that if the modelers are spending time justifying the model
structure, then they are not spending time on other modeling
activities. Phase A of the framework relates to adapting the
framework according to the speciﬁc requirements of the proj-
ect. Model justiﬁcation is always good practice; nevertheless,
less time will be required for conceptual modeling for a simpler
problem. In the present practice, the model type developed is
often based on that which is familiar to the modeler or one
previously used in that area. Training may be required for some
modelers to expand their skills beyond developing decision
trees and Markov models to allow a shift in the approach for
public health modeling.Forrester [46] states that “any worthwhile venture emerges
ﬁrst as an art, and as such the outcomes are special cases and
are poorly transferable, but that this can then be transformed
into a science by understanding the foundations of the art,
making it more useful to new situations.” The research pre-
sented here aims to improve and make transparent the present
understanding of conceptual modeling in public health eco-
nomic evaluation to take the ﬁrst step in moving from an art to
a science. Because this is the ﬁrst framework of this kind, it
provides modelers in public health economic evaluation with a
conceptual modeling process that they are able to critique,
which has not existed before this research.
Although this conceptual modeling framework was developed
by drawing upon different types of decision problems and
contexts, it has not yet been applied in multiple case studies.
The Supplemental Materials found at http://dx.doi.org/10.1016/j.
jval.2016.02.011 provide an illustration of the methods applied to
the diabetes prevention pilot project. The use of the framework in
this case study suggested that it is a potentially useful method.
The diabetes project was complex in terms of the problem, the
relevant stakeholders, and the mathematical model developed.
The conceptual modeling framework provided an approach for
the team to follow to help deal with this complexity. It is
intended that as the conceptual modeling framework is applied
in different projects and as developments in other related
research areas are made, it will be continually improved. Thus,
its use in case studies and future developmental suggestions are
encouraged. Key areas for further research involve evaluation of
the framework in diverse case studies and the development of
methods for modeling individual and social behavior drawing
upon sociology, psychology, and public health.
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